This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →

Permanently Discontinued

APO-TELMISARTAN/HCTZ

APOTEX INC

View this drug's full profile page →

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of APO-TELMISARTAN/HCTZ in Canada?

Yes. APO-TELMISARTAN/HCTZ 25MG 80MG has an active shortage reported to Health Canada (last updated December 20, 2018).

Why is APO-TELMISARTAN/HCTZ not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will APO-TELMISARTAN/HCTZ be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Check with your pharmacist

StatusPermanently Discontinued

Same-ingredient products on fileNone found

Affected strength25MG 80MG

Report last updated2018-05-07

Checked by MedShort2026-11-12

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02420031

Strength

25MG 80MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

HYDROCHLOROTHIAZIDE TELMISARTAN

Tier

Unrated

Last Updated

2018-05-07

Reason for Shortage

Business reasons

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

APO-TELMISARTAN/HCTZ has 3 shortage/discontinuation reports on file — this is one of them.

2018-12-20

Active Shortage

Disruption of the manufacture of the drug.

2018-05-07

Permanently Discontinued

Business reasons

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244